Drug Discovery
  • Target deconvolution
  • Target validation
  • Mode of action analysis
  • Toxicity profiling
Clinical Proteomics
  • Translational research
  • Companion diagnostics
  • Complex biomarker signatures
  • Drug response prediction
Disease and Systems Biology
  • Signal transduction
  • Disease mechanisms
  • Mechanistic biomarkers
  • Multi-omics integration
Accelerating drug and biomarker discovery

OmicScouts is a chemical proteomics company focused on supporting drug and biomarker discovery with its unique expertise and innovative technologies.

Founded by leading proteomics researchers, the company has a track record in delivering significant collaborations with top pharmaceutical and biotechnology companies.

We provide and develop proteome-wide assays that work with native proteins in a physiological setting and enable the identification of small molecule drug targets, target engagement markers, molecular mechanisms of action and drug response biomarkers.

OmicScouts supports your drug and biomarker discovery projects with end-to-end solutions tailored to project specific needs.

Latest News
Nov 7 - Nov 9, 2016
OmicScouts will be at Europe's largest partnering conference BIO-Europe in Cologne. The event attracts large pharma and biotech co...
Nov 29 - Nov 30, 2016
Meet us at the 6th Munich Biomarker Conference discussing how proteomics in concert with genomics and other molecular profiling te...

Scientific excellence in proteomics, computational biology and drug discovery

Read More »

Collaborations with leading academic and industry partners

Read More »

Further informations on job openings

Read More »